How to Buy Marker Therapeutics Stock

Marker Therapeutics Inc

Marker Therapeutics, Inc. , a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications in the United States.

Marker Therapeutics stock last closed at $0.99, up 0% from the previous day, and has decreased 75.6% in one year. It has underperformed other stocks in the Biotechnology industry by 0.55 percentage points. Marker Therapeutics stock is currently +21.98% from its 52-week low of $0.81, and -83.39% from its 52-week high of $5.95.

At the moment, there are 12.94M MRKR shares outstanding. The market capitalization of MRKR is $12.78M. In the past 24 hours, 94,000 MRKR shares were traded.

How to Buy Marker Therapeutics Stock

Wondering how to invest in Marker Therapeutics stock? Here's how.

  1. Choose where to buy Marker Therapeutics stock: You need to decide on a stock brokerage, but don't worry - we've sifted through dozens of online brokerages and apps to help you determine where to buy Marker Therapeutics stock.
  2. Create your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've identified.
  3. Fund your brokerage account: Select your payment method and add your information.
  4. Evaluate Marker Therapeutics stock: The Marker Therapeutics ticker symbol is MRKR. Is Marker Therapeutics stock a good investment? Should you buy shares of MRKR? How do MRKR's underlying business fundamentals look? Do top analysts think Marker Therapeutics is a good buy? Why has MRKR's stock price moved recently? (Hint: Our stock market analysis tools can help you evaluate if MRKR is a good stock to buy).
  5. Place your MRKR purchase: Decide if you will purchase MRKR shares at the current market price or use a limit order to purchase MRKR shares at a specific price.
  6. Get notifications regarding your MRKR position: Create a watchlist to important notifications about your position in Marker Therapeutics shares.

Step 1: Choose where to buy Marker Therapeutics stock

You need an online brokerage account to access the NASDAQ market and buy MRKR stock.

A brokerage account is an investment account that enables you to buy and sell a number of investments, including stocks, bonds, mutual funds, and ETFs.

Our recommended brokerage: eToro

Based on our research, eToro is the best place to buy stocks. Here's why:

  • Invest in stocks with 0% commissions: Invest without paying trading commissions.
  • Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
  • Access to world financial markets: From Tech to Healthcare, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top exchanges.
  • Social investing: eToro has a community with more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of other investors.
  • Security: eToro is a regulated and licensed brokerage platform.
  • Buy other assets: Such as ETFs and cryptocurrencies.

Get $10 towards your stock purchase by signing up for an account with eToro today. This offer is only for US users.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Create your brokerage account

Now that you've chosen the right brokerage, you'll need to fill out some personal information so you can buy MRKR today.

How to Open a New Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Provide your personal data to start a new trading account.
  1. Submit your application by pressing the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Fund your brokerage account

Now that you've finished signing up on the best stock investing app, your next step is to transfer the money for your investment:

Watch the tutorial below if you need help transferring funds into your brokerage account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Evaluate Marker Therapeutics stock

Once you have selected the best place to buy Marker Therapeutics stock, it's absolutely critical to research their stock before you invest, so you actually wrap your head around the risk as well as the opportunity.

Marker Therapeutics quick stats

MRKR Price
$0.99
1w %
-4.08%
1y %
-75.6%
5y %
-92.74%
P/E
-0.72x
P/B
1.22x
P/S
2.56x
PEG
N/A
Revenue
$5.39M
Earnings
-$14.61M
Fore. Rev. Growth
64.82%
Fore. Earn. Growth
N/A
Market Cap
$12.78M
Next Earnings
N/A
Next Dividend
N/A

MRKR Due Diligence Score

WallStreetZen was built to help part-time investors do better fundamental analysis.

You can see all of the due diligence checks on MRKR's stock page.

Is MRKR stock undervalued?

You can use many financial metrics, analyses, models, and charts to gauge MRKR's true value.

Using relative valuations measures:

  • MRKR may be undervalued based on its P/B ratio of 1.22x, relative to Biotechnology industry P/B ratio of 4.99x

You can do additional valuation research on MRKR's stock here.

A look at MRKR Cashflows and Balance Sheet

Passed Health Checks:

  • MRKR has $11.81M in cash and short term investments. This is sufficient to cover its annual cash burn of $10.88M.
  • There are more short-term assets than long-term liabilities on the MRKR balance sheet.
  • MRKR has cash burn of 10883735. It has sufficient cash and short-term investments to cover this for at least one year.
  • There are more short-term assets than short-term liabilities on the MRKR balance sheet.

Failed Health Checks:

  • Total MRKR debt is higher than 5 years ago, relative to shareholder equity.
  • MRKR has a relatively high debt to equity ratio of 0.41.
  • MRKR profit margin has gone up by 0.07 percentage points in the past year, but the company is still unprofitable.

You can dig deeper into what analysts are forecasting on the Marker Therapeutics stock forecast page.

MRKR Momentum

SMA10
1.01
SMA20
1.03
SMA50
0.98
SMA100
1.22
SMA200
1.33
MACD
0
MACD Signal
0
MACD Histogram
0
RSI
47.25
Stochastic %K
20.74
Stochastic %D
24.96
StochRSI %K
15.62
StochRSI %D
17.29

MRKR Earnings

Last year, MRKR revenue was $5.39M. Over the past five year, MRKR's revenue has increased by 51.28% per year. This was slower than the Biotechnology industry average of 68.21%.

Dig into MRKR's earnings and revenue performance here.

Are MRKR executives and large shareholders buying or selling the stock?

In the past year, insiders at MRKR have bought more shares than they have sold.

Steve Elms, Director of MRKR, was the latest MRKR insider to buy. They bought $35,472.00 worth of MRKR shares on Dec 23, 2024.

Dig into more about who owns MRKR stock here.

Does MRKR provide a stable income stream?

No, Marker Therapeutics doesn't provide an income stream by paying out dividends.

MRKR Social Trading Data

One of the reasons eToro is our favorite brokerage is because of its social trading community.

Click below to learn what other traders have to say.

Step 5: Place your MRKR purchase

There are two primary options:

  • Market order: A market order is an order to buy or sell a security at the best price on the market.
    Market orders are generally sufficient.
  • Limit order: A limit order enables you to buy or sell a stock at a specific price (or better).
    If you want to make sure you're buying or selling at a given dollar amount limit, use a limit order.

Hit the Open Trade button and your broker will execute the order.

If you need additional help with investing in stocks on eToro, watch the how to video below:

Open eToro Account

Step 6: Get notifications regarding your MRKR position

Now that you own some MRKR shares, you'll want to stay up-to-date on your new shares.

Start a watchlist to track the latest developments regarding your MRKR stock.

MRKR Feed

How to Buy Stock in Marker Therapeutics

To summarize, here are the 6 steps for buying Marker Therapeutics stock:

  1. Choose where to buy Marker Therapeutics stock
  2. Create your brokerage account
  3. Fund your brokerage account
  4. Evaluate Marker Therapeutics stock
  5. Place your MRKR purchase
  6. Get notifications regarding your MRKR position

If you require a brokerage account, eToro is our recommended option.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you want to get notifications regarding your new investment in Marker Therapeutics, create a watchlist today.

NASDAQ: MRKR
$0.99+0.00 (+0%)
Updated Oct 31, 2025
Open eToro Account
Your capital is at risk.
NASDAQ: MRKR
$0.99+0.00 (+0%)
Updated Oct 31, 2025
Open eToro Account
Your capital is at risk.

FAQ

How much does it cost to buy one Marker Therapeutics share?

As of Oct 31, 2025, it costs $0.99 to buy one share of Marker Therapeutics stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $0.49, you can buy 0.5 shares of MRKR.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

What is the best way to buy Marker Therapeutics stock?

One way to place an order for Marker Therapeutics stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.